Eosinophilic inflammation in allergic asthma

Frontiers in Pharmacology

Volumn 4 APR, Issue , 2013, Pages

  Possa, Samantha S ^a   Leick, Edna A ^a   Prado, Carla M ^b   Martins, Mílton A ^a   Tibério, Iolanda F L C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Airway remodeling; Asthma; Eosinophils; Experimental models of asthma; Inflammation; Respiratory hypersensitivity

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; DEXAMETHASONE; EOTAXIN; FASUDIL; INTERLEUKIN 13; INTERLEUKIN 5; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; N(G) NITROARGININE METHYL ESTER; RHO KINASE INHIBITOR; XRCC3 PROTEIN;

AIRWAY REMODELING; ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; CHRONIC INFLAMMATION; CLARA CELL; CYTOKINE PRODUCTION; DRUG EFFICACY; EOSINOPHIL; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LUNG PARENCHYMA; NEUTROPHIL CHEMOTAXIS; NONHUMAN; RESPIRATORY TRACT ALLERGY; REVIEW; TH2 CELL;

EID: 84881506204     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2013.00046     Document Type: Review

References (122)

1. Aceves, S. S., and Broide, D. H. (2008). Airway fibrosis and angiogenesis due to eosinophil trafficking in chronic asthma. Curr. Mol. Med. 8, 350-358.
2. Adamko, D. J., Yost, B. L., Gleich, G. J., Fryer, A. D., and Jacoby, D. B. (1999). Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection. Eosinophils mediate airway hyperresponsiveness, m(2) muscarinic receptor dysfunction, and antiviral effects. J. Exp. Med. 90, 1465-1478.
3. Aihara, M., Dobashi, K., Iizuka, K., Nakazawa, T., and Mori, M. (2003). Comparison of effects of Y-27632 and Isoprotenerol on release of cytolines from human peripheral T cells. Int. Immunopharmacol. 3, 1619-1625.
4. Aihara, M., Dobashi, K., Iizuka, K., Nakazawa, T., and Mori, M. (2004). Effect of Y-27632 on release of cytokines from peripheral T cells in asthmatic patients and normal subjects. Int. Immunopharmacol. 4, 557-561.
5. Akuthota, P., Xenakis, J. J., and Weller, P. F. (2011). Eosinophils: offenders or general bystanders in allergic airway disease and pulmonary immunity? J. Innate Immun. 3, 113-119.
6. Angeli, P., Prado, C. M., Xisto, D. G., Silva, P. L., Pássaro, C. P., Nakazato, H. D., et al. (2008). Effects of chronic L-NAME treatment lung tissue responses induced by chronic pulmonary inflammation mechanics, eosinophilic and extracellular matrix. Am. J. Physiol. Lung Cell. Mol. Physiol. 294, L1197-L1205.
7. Araujo, B. B., Dolhnikoff, M., Silva, L. F., Elliot, J., Lindeman, J. H., Ferreira, D. S., et al. (2008). Extracellular matrix components and regulators in the airway smooth muscle in asthma. Eur. Respir. J. 32, 61-69.
8. Blain, J. F., and Sirois, P. (2000). Involvement of LTD4 in allergic pulmonary inflammation in mice: modulation by cysLT1 antagonist MK-571. Prostaglandins Leukot. Essent. Fatty Acids 62, 361-368.
9. Blease, K., Kunkel, S. L., and Hogaboam, C. M. (2000). Acute inhibition of nitric oxide exacerbates airway hyperresponsiveness, eosinophilia and C-C chemokine generation in a murine model of fungal asthma. Inflamm. Res. 49, 297-304.
10. Brightling, C. E. (2001). Eosinophils, bronchitis and asthma: pathogenesis of cough and airflow obstruction. Pulm. Pharmacol. Ther. 24, 324-327.
11. Busse, W., and Kraft, M. (2005). Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy. Chest 127, 1312-1326.
12. Busse, W. W. (2001). Does leukotriene modulation of eosinophil function explain the therapeutic effectiveness of receptor antagonists in some patients with asthma? Clin. Exp. Allergy 31, 806-807.
13. Busse, W. W., and Sedgwick, J. B. (1992). Eosinophils in asthma. Ann. Allergy 68, 286-290.
14. Chung, Y., Cho, J., Chang, Y. S., Cho, S. H., and Kang, C. Y. (2002). Preventive and therapeutic effects of oral tolerance in a murine model of asthma. Immunobiology 206, 408-423.
15. Das, A. M., Vaddi, K. G., Solomon, K. A., Krauthauser, C., Jiang, X., McIntyre, K. W., et al. (2006). Selective inhibition of eosinophil influx into the lung by small molecule CC chemokine receptor 3 antagonists in mouse models of allergic inflammation. J. Pharmacol. Exp. Ther. 318, 411-417.
16. Dolhnikoff, M., Mauad, T., and Ludwig, M. S. (1999). Extracellular matrix and oscillatory mechanics of rat lung parenchyma in bleomycin-induced fibrosis. Am. J. Respir. Crit. Care Med. 160, 1750-1757.
17. Drazen, J. M. (1998). Leukotrienes as mediators of airway obstruction. Am. J. Respir. Crit. Care Med. 158, S193-S200.
18. Drazen, J. M., Israel, E., and O'Byrne, P. M. (1999). Treatment of asthma with drugs modifying the leukotriene pathway. N. Engl. J. Med. 340, 197-206.
19. Esnault, S., Kelly, E. A., Nettenstrom, L. M., Cook, E. B., Seroogy, C. M., and Jarjour, N. N. (2012). Human eosinophils release IL-1ß and increase expression of IL-17A in activated CD4(+) T lymphocytes. Clin. Exp. Allergy 42, 1756-1764.
20. Evans, C. M., Fryer, A. D., Jacoby, D. B., Gleich, G. J., and Costello, R. W. (1997). Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. J. Clin. Invest. 100, 2254-2262.
21. Eynott, P. R., Groneberg, D. A., Caramori, G., Adcock, I. M., Donnely, L. E., Kharitonov, S., et al. (2002). Role of nitric oxide in allergic inflammation and bronchial hyperresponsiveness. Eur. J. Pharmacol. 452, 123-133.
22. Fanat, A. I., Thomson, J. V., Radford, K., Nair, P., and Sehmi, R. (2009). Human airway smooth muscle promotes eosinophil differentiation. Clin. Exp. Allergy 39, 1009-1017.
23. Fanta, C., Bohle, B., Hirt, W., Siemann, U., Horak, F., Kraft, D., et al. (1999). Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy. Int. Arch. Allergy Immunol. 120, 218-224.
24. Fattouh, R., and Jordana, M. (2008). TGF-beta, eosinophils and IL-13 in allergic airway remodeling: a critical appraisal with therapeutic considerations. Inflamm. Allergy Drug Targets 7, 224-236.
25. Feder, L. S., Stelts, D., Chapman, R. W., Manfra, D., Crawley, Y., Jones, H., et al. (1997). Role of nitric oxide on eosinophilic lung inflammation in allergic mice. Am. J. Respir. Cell. Mol. Biol. 17, 436-442.
26. Ferreira, H. H. A., Bevilacqua, E., Gagioti, S. M., De Luca, I. M. S., Zanardo, R. C. O., Teixeira, C. E., et al. (1998). Nitric oxide modulates eosinophil infiltration in antigen-induced airway inflammation in rats. Eur. J. Pharmacol. 358, 253-258.
27. Foster, A., and Chan, C. C. (1991). Peptide leukotriene involvement in pulmonary eosinophil migration upon antigen challenge in the actively sensitized guinea pig. Int. Arch. Allergy Appl. Immunol. 96, 279-284.
28. Foster, P. S., Rosenberg, H. F., Asquith, K. L., and Kumar, R. K. (2008). Targeting eosinophils in asthma. Curr. Mol. Med. 8, 585-590.
29. Gauvreau, G. M., Ellis, A. K., and Denburg, J. A. (2009). Haemopoietic processes in allergic disease: eosinophil/basophil development. Clin. Exp. Allergy 39, 1297-1306.
30. Ghosh, S., Hoselton, S. A., Dorsam, G. P., and Schuh, J. M. (2013). Eosinophils in fungus-associated allergic pulmonary disease. Front. Pharmacol. 4:8. doi:10.3389/fphar.2013.00008
31. Gibson, P. G., Saltos, N., and Borgas, T. (2000). Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid-treated asthma. J. Allergy Clin. Immunol. 105, 752-759.
32. Global Initiative for Asthma (GINA). (2011). Global Strategy for Asthma Management and Prevention. Available at: http://www.ginasthma.org.
33. Gundel, R. H., Letts, L. G., and Gleich, G. J. (1991). Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J. Clin. Invest. 87, 1470-1473.
34. Hahn, C., Islamian, A. P., Renz, H., and Nockher, W. A. (2006). Airway epithelial cells produce neurotrophins and promote the survival of eosinophils during allergic airway inflammation. J. Allergy Clin. Immunol. 117, 787-794.
35. Halwani, R., Vazquez-Tello, A., Sumi, Y., Pureza, M. A., Bahammam, A., Al-Jahdali, H., et al. (2013). Eosinophils induce airway smooth muscle cell proliferation. J. Clin. Immunol. 33, 595-604.
36. Hashimoto, T., Nakano, Y., Yamashita, M., Fang, Y., Ohata, H., and Momose, K. (2002). Role of Rho-associated protein kinase and histamine in lysophosphatidic acid induced airway hyperresponsiveness in guinea pigs. Jpn. J. Pharmacol. 88, 256-261.
37. Hendeles, L., Asmus, M., and Chresrown, S. (2004). Evaluation of cytokine modulators for asthma. Paediatr. Respir. Rev. 25, 107-112.
38. Henderson, W. R. Jr., Tang, L. O., Chu, S. J., Tsao, S. M., Chiang, G. K., Jones, F., et al. (2002). A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am. J. Respir. Crit. Care Med. 165, 108-116.
39. Henry, P. J., Mann, T. S., and Goldie, R. G. (2005). A Rho kinase inhibitor, Y-27632 inhibits pulmonary eosinophilia, bronchoconstriction and airways hyperresponsiveness in allergic mice. Pulm. Pharmacol. Ther. 18, 67-74.
40. Holgate, S. (2001). Mechanisms of allergy and adult asthma. Curr. Opin. Allergy Clin. Immunol. 1, 47-50.
41. Holgate, S. T., and Sampson, A. P. (2000). Antileukotriene therapy: future directions. Am. J. Respir. Crit. Care Med. 61, S147-153.
42. Huang, F. Y., Wang, C. C., Zhou, S. L., Huang, Y. H., Wang, H., Chen, F., et al. (2009). Antisense interleukin-5 reduces eosinophil infiltration and hyperresponsiveness in an allergic asthma model. Asian Pac. J. Allergy Immunol. 27, 35-41.
43. Iijima, H., Duguet, A., Eum, S. Y., Hamid, Q., and Eidelman, D. H. (2001). Nitric oxide and protein nitration are eosinophil dependent in allergen-challenged mice. Am. J. Respir. Crit. Care Med. 163, 1233-1240.
44. Ilmarinen-Salo, P., Moilanen, E., Kinnula, V. L., and Kankaanranta, H. (2012). Nitric oxide-induced eosinophil apoptosis is dependent on mitochondrial permeability transition (mPT), JNK and oxidative stress: apoptosis is preceded but not mediated by early mPT-dependent JNK activation. Respir. Res. 13, 73.
45. Isobe, Y., Kato, T., and Arita, M. (2012). Emerging roles of eosinophils and eosinophil-derived lipid mediators in the resolution of inflammation. Front. Immunol. 3:270. doi:10.3389/fimmu.2012.00270
46. Iwashita, H., Morita, S., Sagiya, Y., and Nakanishi, A. (2006). Role of eosinophil chemotactic factor by T lymphocytes on airway hyperresponsiveness in a murine model of allergic asthma. Am. J. Respir. Cell. Mol. Biol. 35, 103-109.
47. Jacobsen, A., Helmers, R. A., Lee, J. J., and Lee, N. A. (2012). The expanding role(s) of eosinophils in health and disease. Blood 120, 3882-3890.
48. Jacobsen, E. A., Zellner, K. R., Colbert, D., Lee, N. A., and Lee, J. J. (2011). Eosinophils regulate dendritic cells and Th2 pulmonary immune responses following allergen provocation. J. Immunol. 187, 6059-6068.
49. Kanda, A., Driss, V., Hornez, N., Abdallah, M., Roumier, T., Abboud, G., et al. (2009). Eosinophil-derived IFN-gamma induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes. J. Allergy Clin. Immunol. 124, 573-582.
50. Kang, B. N., Ha, S. G., Ge, X. N., Reza Hosseinkhani, M., Bahaie, N. S., Greenberg, Y., et al. (2012). The p110δ subunit of PI3K regulates bone marrow-derived eosinophil trafficking and airway eosinophilia in allergen-challenge mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 302, L1179-1191.
51. Kariyawasam, H. H., and Robinson, D. S. (2007). The role of eosinophils in airway tissue remodelling in asthma. Curr. Opin. Immunol. 19, 681-686.
52. Kato, M., Suzuki, M., Hayashi, Y., and Kimura, H. (2006). Role of eosinophils and their clinical significance in allergic inflammation. Expert Rev. Clin. Immunol. 2, 121-133.
53. Kay, A. B. (2005). The role of eosinophils in the pathogenesis of asthma. Trends Mol. Med. 11, 148-152.
54. Keller, A. C., Mucida, D., Gomes, E., Faquim-Mauro, E., Faria, A. M., Rodriguez, D., et al. (2006). Hierarchical suppression of asthma-like responses by mucosal tolerance. J. Allergy Clin. Immunol. 117, 283-290.
55. Kikkawa, Y., Sugiyama, K., Obara, K., Hirata, H., Fukushima, Y., Toda, M., et al. (2012). Interferon-alpha inhibits airway eosinophila and hyperresponsiveness in an animal asthma model. Asia Pac. Allergy 2, 256-263.
56. Kim, S. H., and Lee, Y. C. (2009). Piperine inhibits eosinophil infiltration and airway hyperresponsiveness by suppressing T cell activity and Th2 cytokine production in the ovalbumin-induced asthma model. J. Pharm. Pharmacol. 61, 353-359.
57. Kraneveld, A. D., van Ark, I., Van Der Linde, H. J., Fattah, D., Nijkamp, F. P., and Van Oosterhout, A. J. (1997). Antibody to very late activation antigen 4 prevents interleukin-5-induced airway hyperresponsiveness and eosinophil infiltration in the airways of guinea pigs. J. Allergy Clin. Immunol. 100, 242-250.
58. Lancas, T., Kasahara, D. I., Prado, C. M., Tiberio, I. F., Martins, M. A., and Dolhnikoff, M. (2006). Comparison of early and late responses to antigen of sensitized guinea pig parenchymal lung strips. J. Appl. Physiol. 100, 1610-1616.
59. Leckie, M. J., ten Brinke, A., Khan, J., Diamant, Z., O'Connor, B. J., Walls, C. M., et al. (2000). Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 356, 2144-2148.
60. Lee, J. J., Jacobsen, E. A., McGarry, M. P., Schleimer, R. P., and Lee, N. A. (2010). Eosinophils in health and disease: the LIAR hypothesis. Clin. Exp. Allergy 40, 563-575.
61. Leick, E. A., Reis, F. G., Honorio-Neves, F. A., Almeida-Reis, R., Prado, C. M., Martins, M. A., et al. (2012). Effects of repeated stress on distal airway inflammation, remodeling and mechanics in an animal model of chronic airway inflammation. Neuroimmunomodulation 19, 1-9.
62. Leick-Maldonado, E. A., Kay, F. U., Leonhardt, M. C., Kasahara, D. I., Prado, C. M., Fernandes, F. T., et al. (2004). Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in an experimental model of chronic airway inflammation in guinea-pigs. Clin. Exp. Allergy 34, 145-152.
63. Lemanske, R. F., and Busse, W. W. (2010). Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol. 125, 95-102.
64. Liang, Z., Zhao, H., Lv, Y., Li, R., Dong, H., Liu, L., et al. (2012). Moderate accuracy of peripheral eosinophil count for predicting eosinophilic phenotype in steroid-naïve non-atopic adult asthmatics. Intern. Med. 51, 717-722.
65. Lim, D. H., Cho, J. Y., Sopng, D. J., Lee, S. Y., Miller, M., and Broide, D. H. (2009). PI3K gamma-defficient mice have reduced levels of allergen-induced eosinophilic inflammation and airway remodeling. Am. J. Physiol. Lung Cell. Mol. Physiol. 296, L210-219.
66. Liu, L. Y., Mathur, S. K., Sedgwick, J. B., Jarjour, N. N., Busse, W. W., and Kelly, E. (2006). A. Human airway and peripheral blood eosinophils enhance Th1 and Th2 cytokine secretion. Allergy 61, 589-597.
67. Lu, Y., Sjöstrand, M., Malmhäll, C., Rådinger, M., Jeurink, P., Lötvall, J., et al. (2010). New production of eosinophils and the corresponding TH1/TH2 balance in the lungs after allergen exposure in BALB/c and C57BL/6 mice. Scand. J. Immunol. 71, 176-185.
68. Machida, K., Inoue, H., Matsumoto, K., Tsuda, M., Fukuyama, S., Koto, H., et al. (2005). Activation of PI3KAkt pathway mediates antiapoptotic effects of beta-adrenergic agonist in airway eosinophils. Am. J. Physiol. Lung Cell. Mol. Physiol. 288, L860-L867.
69. Malm-Erjefält, M., Greiff, L., Ankerst, J., Andersson, M., Wallengren, J., Cardell, L. O., et al. (2005). Circulating eosinophils in asthma, allergic rhinitis, and atopic dermatitis lack morphological signs of degranulation. Clin. Exp. Allergy 35, 1334-1340.
70. Marques, R. H., Reis, F. G., Starling, C. M., Cabido, C., de Almeida-Reis, R., Dohlnikoff, M., et al. (2012). Inducible nitric oxide synthase inhibition attenuates physical stress-induced lung hyperresponsiveness and oxidative stress in animals with lung inflammation. Neuroimmunomodulation 19, 158-170.
71. Mattes, J., and Foster, P. S. (2003). Regulation of eosinophil migration and Th2 cell function by IL-5 and eotaxin. Curr. Drug Targets Inflamm. Allergy 2, 169-174.
72. Mauad, T., Silva, L. F., Santos, M. A., Grinberg, L., Bernardi, F. D., Martins, M. A., et al. (2004). Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. Am. J. Respir. Crit. Care Med. 170, 857-862.
73. Molfino, N. A. (2012). Targeting of eosinophils in asthma. Expert Opin. Biol. Ther. 12, 807-809.
74. Mullol, J., Callejas, F. B., Méndez-Arancibia, E., Fuentes, M., Alobid, I., Martínez-Antón, A., et al. (2010). Montelukast reduces eosinophilic inflammation by inhibiting both epithelial cell cytokine secretion (GM-CSF, IL-6, IL-8) and eosinophil survival. J. Biol. Regul. Homeost. Agents 24, 403-411.
75. Muraki, M., Imbe, S., Santo, H., Sato, R., Sano, H., Iwanaga, T., et al. (2011). Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model. Int. Arch. llergy Immunol. 155, 90-95.
76. Nakashima, A. S., Prado, C. M., Lancas, T., Ruiz, V. C., Kasahara, D. I., Leick-Maldonado, E. A., et al. (2008). Oral tolerance attenuates changes in in vitro lung tissue mechanics and extracellular matrix remodeling induced by chronic allergic inflammation in guinea pigs. J. Appl. Physiol. 104, 1778-1785.
77. Nittoh, T., Fujimori, H., Kozumi, Y., Ishihara, K., Mue, S., and Ohuchi, K. (1998). Effects of glucocorticoids on apoptosis of infiltrated eosinophils and neutrophils in rats. Eur. J. Pharmacol. 354, 73-81.
78. Numao, T., and Agrawal, D. K. (1992). Neuropeptides modulate human eosinophil chemotaxis. J. Immunol. 149, 3309-3315.
79. Obase, Y., Shimoda, T., Mitsuta, K., Matsuo, N., Matsuse, H., and Kohno, S. (2001). Correlation between airway hyperresponsiveness and airway inflammation in a young adult population: eosinophil, ECP, and cytokine levels in induced sputum. Ann. Allergy Asthma Immunol. 86, 304-310.
80. O'Byrne, P. M. (2000). Leukotriene bronchoconstriction induced by allergen and exercises. Am. J. Respir. Crit. Care Med. 161, S68-72.
81. Ohnishi, H., Miyahara, N., and Gelfand, E. W. (2008). The role of leukotrien B(4) in allergic diseases. Allergol. Int. 57, 291-298.
82. Ohtomo, T., Kaminuma, O., Yamada, J., Kitamura, N., Abe, A., Kobayashi, N., et al. (2010). Eosinophils are required for the induction of bronchial hyperresponsiveness in a Th transfer model of BALB/c background. Int. Arch. Allergy Immunol. 152, 79-82.
83. Park, S. J., Lee, K. S., Kim, S. R., Min, K. H., Moon, H., Lee, M. H., et al. (2010). Phosphoinositide 3-kinase δ inhibitor suppresses interleukin-17 expression in a murine asthma model. Eur. Respir. J. 36, 1448-1459.
84. Phipps, S., Benyahia, F., Ou, T. T., Barkans, J., Robinson, D. S., and Kay, A. B. (2004). Acute allergen-induced airway remodeling in atopic asthma. Am. J. Respir. Cell Mol. Biol. 31, 626-632.
85. Pope, S. M., Brandt, E. B., Mishra, A., Hogan, S. P., Zimmermann, N., Matthaei, K. I., et al. (2001). IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J. Allergy Clin. Immunol. 108, 594-601.
86. Possa, S. S., Charafeddine, H. T., Righetti, R. F., da Silva, P. A., Almeida-Reis, R., Saraiva-Romanholo, B. M., et al. (2012). Rho-kinase inhibition attenuates airway responsiveness, inflammation, matrix remodeling, and oxidative stress activation induced by chronic inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 11, L939-L952.
87. Pouliot, P., and Olivier, M. (2009). Opposing forces in asthma: regulation of signaling pathways by kinases and phosphatases. Crit. Rev. Immunol. 29, 419-442.
88. Prado, C. M., Leick-Maldonado, E. A., Kasahara, D. I., Capelozzi, V. L., Martins, M. A., and Tibério, I. F. L. C. (2005a). Effects of acute and chronic nitric oxide inhibition in an experimental model of chronic pulmonary allergic inflammation in guinea pigs. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L677-683.
89. Prado, C. M., Leick-Maldonado, E. A., Arata, V., Kasahara, D. I., Martins, M. A., and Tibério, I. F. L. C. (2005b). Neurokinins and inflammatory cell iNOS expression in guinea pigs with chronic allergic airway inflammation. Am. J. Physiol. 288, L741-748.
90. Prado, C. M., Leick-Maldonado, E. A., Yano, L., Leme, A. S., Capelozzi, V. L., Martins, M. A., et al. (2006). Effects of nitric oxide synthases in chronic allergic airway inflammation and remodeling. Am. J. Respir. Cell. Mol. Biol. 35, 457-465.
91. Rocco, P. R., Negri, E. M., Kurtz, P. M., Vasconcellos, F. P., Silva, G. H., Capelozzi, V. L., et al. (2001). Lung tissue mechanics and extracellular matrix remodeling in acute lung injury. Am. J. Respir. Crit. Care Med. 164, 1067-1071.
92. Rosenberg, H. F., Dyer, K. D., and Foster, P. S. (2013). Eosinophils: changing perspectives in health and disease. Nat. Rev. Immunol. 13, 9-22.
93. Ruiz-Schütz, V. C., Drewiacki, T., Nakashima, A. S., Arantes-Costa, F. M., Prado, C. M., Kasahara, D. I., et al. (2009). Oral tolerance attenuates airway inflammation and remodeling in a model of chronic pulmonary allergic inflammation. Respir. Physiol. Neurobiol. 165, 13-21.
94. Russo, M., Jancar, S., Pereira de Siqueira, A. L., Mengel, J., Gomes, E., Ficker, S. M., et al. (1998). Prevention of lung eosinophilic inflammation by oral tolerance. Immunol Lett. 61, 15-23.
95. Russo, M., Nahori, M. A., Lefort, J., Gomes, E., de Castro Keller, A., Rodriguez, D., et al. (2001). Suppression of asthma-like responses in different mouse strains by oral tolerance. Am. J. Respir. Cell. Mol. Biol. 24, 518-526.
96. Sagara, H., Yukawa, T., Arima, M., and Makino, S. (1993). Effects of capsaicin on the migration of eosinophils into the bronchi of guinea pigs. Aerugi 42, 236-242.
97. Schaafsma, D., Bos, S. T., Zuidhof, A. B., Zaagsma, J., and Meurs, H. (2008). The inhaled Rho kinase inhibitor Y-27632 protects against allergen-induced acute bronchoconstriction, airway hyperresponsiveness, and inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L214-L219.
98. Schaafsma, D., Gosens, R., Bos, S. T., Meurs, H., Zaagsma, J., and Nelemans, A. (2004). Allergic sensitization enhances the contribution of Rho-kinase to airway smooth muscle contraction. Br. J. Pharmacol. 143, 477-484.
99. Schuiling, M., Meurs, H., Zuidhof, A. B., Venema, N., and Zaagsma, J. (1998). Dual action of iNOS-derived nitric oxide in allergy-induced airway hyperreactivity in conscious, unrestrained guinea pigs. Am. J. Respir. Crit. Care Med. 158, 1442-1449.
100. Schwartz, N., Grossman, A., Levy, Y., and Schwarz, Y. (2012). Correlation between eosinophil count and methacholine challenge test in asymptomatic subjects. J. Asthma 49, 336-341.
101. Shamri, R., Xenakis, J. J., and Spencer, L. A. (2011). Eosinophils in innate immunity: an evolving story. Cell Tissue Res. 343, 57-83.
102. Sonar, S. S., Ehmke, M., Marsh, L. M., Dietze, J., Dudda, J. C., Conrad, M. L., et al. (2012). Clara cells drive eosinophil accumulation in allergic asthma. Eur. Respir. J. 39, 429-438.
103. Spector, S. L., and Tan, R. A. (2012). Is a single blood eosinophil count a reliable marker for "eosinophilic asthma?". J. Asthma 49, 807-810.
104. Spencer, L. A., Szela, C. T., Perez, S. A., Kirchhoffer, C. L., Neves, J. S., Radke, A. L., et al. (2009). Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially. J. Leukoc. Biol. 85, 117-123.
105. Starling, C. M., Prado, C. M., Leick-Maldonado, E. A., Lanças, T., Reis, F. G., Aristóteles, L. R., et al. (2009). Inducible nitric oxide synthase inhibition attenuates lung tissue responsiveness and remodeling in a model of chronic pulmonary inflammation in guinea pigs. Respir. Physiol. Neurobiol. 165, 185-194.
106. Taki, F., Kume, H., Kobayashi, T., Ohta, H., Aratake, H., and Shimokata, K. (2007). Effects of Rho-kinase inactivation on eosinophilia and hyper-reactivity in murine airways by allergen challenges. Clin. Exp. Allergy 37, 599-607.
107. Taylor, E. L., Megson, I. L., Haslett, C., and Rossi, A. G. (2003). Nitric oxide: a key regulator of myeloid inflammatory cell apoptosis. Cell Death Differ. 10, 418-430.
108. Tibério, I. F., Leick-Maldonado, E. A., Miyahara, L., Kasahara, D. I., Spilborghs, G. M., Martins, M. A., et al. (2003). Effects of neurokinins on airway and alveolar eosinophil recruitment. Exp. Lung Res. 29, 165-177.
109. Tibério, I. F., Turco, G. M., Leick-Maldonado, E. A., Sakae, R. S., Paiva, S. O., do Patrocinio, M., et al. (1997). Effects of neurokinin depletion on airway inflammation induced by chronic antigen exposure. Am. J. Respir. Crit. Care Med. 155, 1739-1747.
110. Trivedi, S. G., and Lloyd, C. M. (2007). Eosinophils in the pathogenesis of allergic airways disease. Cell. Mol. Life Sci. 64, 1269-1289.
111. Uhm, T. G., Kim, B. S., and Chung, I. Y. (2012). Eosinophil development, regulation of eosinophil-specific genes, and role of eosinophils in the pathogenesis of asthma. Allergy Asthma Immunol. Res. 4, 68-79.
112. Vaickus, L. J., Bouchard, J., Kim, J., Natarajan, S., and Remick, D. G. (2010). Oral tolerance inhibits pulmonary eosinophilia in a cockroach allergen induced model of asthma: a randomized laboratory study. Respir. Res. 11, 160.
113. Venge, P. (2010). The eosinophil and airway remodelling in asthma. Clin. Respir. J. 4, 15-19.
114. Vignola, A. M., Kips, J., and Bousquet, J. (2000). Tissue remodeling as a feature of persistent asthma. J. Allergy. Clin. Immunol. 105, 1041-1053.
115. Vignola, A. M., Mirabella, F., Costanzo, G., Di Giorgi, R., Gjomarkaj, M., Bellia, V., et al. (2003). Airway remodeling in asthma. Chest 123, 417S-422S.
116. Walsh, G. M. (2010). Targeting eosinophils in asthma: current and future state of cytokine- and chemokine-directed monoclonal therapy. Expert Rev. Clin. Immunol. 6, 701-704.
117. Wardlaw, A. J. (1999). Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm. J. Allergy. Clin. Immunol. 104, 917-926.
118. Watt, A. P., Schock, B. C., and Ennis, M. (2005). Neutrophils and eosinophils: clinical implications of their appearance, presence and disappearance in asthma and COPD. Curr. Drug Targets Inflamm. Allergy 4, 415-423.
119. Weinstock, J. V., Blum, A., Walder, J., and Walder, R. (1988). Eosinophils from granulomas in murine Schistosomiasis mansoni produce substance P. J. Immunol. 141, 961-966.
120. Xisto, D. G., Farias, L. L., Ferreira, H. C., Picanco, M. R., Amitrano, D., Lapa, E. S. J. R., et al. (2005). Lung parenchyma remodeling in a murine model of chronic allergic inflammation. Am. J. Respir. Crit. Care Med. 171, 829-837.
121. Yoshii, A., Iizuka, K., Dobashi, K., Horie, T., Harada, T., Nakazawa, T., et al. (1999). Relaxation of contracted rabbit tracheal and human bronchial smooth muscle by Y-27632 through inhibition of Ca2+ sensitization. Am. J. Respir. Cell. Mol. Biol. 20, 1190-1200.
122. Zhu, M., Liu, P. Y., Kasahara, D. I., Williams, A. S., Verbout, N. G., Halayko, A. J., et al. (2011). Role of Rho kinase isoforms in murine allergic airway responses. Eur. Respir. J. 38, 841-850.